Science and Research

Advances in antibiotic therapy in the critically ill

Infections occur frequently in critically ill patients and their management can be challenging for various reasons, including delayed diagnosis, difficulties identifying causative microorganisms, and the high prevalence of antibiotic-resistant strains. In this review, we briefly discuss the importance of early infection diagnosis, before considering in more detail some of the key issues related to antibiotic management in these patients, including controversies surrounding use of combination or monotherapy, duration of therapy, and de-escalation. Antibiotic pharmacodynamics and pharmacokinetics, notably volumes of distribution and clearance, can be altered by critical illness and can influence dosing regimens. Dosing decisions in different subgroups of patients, e.g., the obese, are also covered. We also briefly consider ventilator-associated pneumonia and the role of inhaled antibiotics. Finally, we mention antibiotics that are currently being developed and show promise for the future.

  • Vincent, J. L.; Bassetti, M.; Francois, B.; Karam, G.; Chastre, J.; Torres, A.; Roberts, J. A.; Taccone, F. S.; Rello, J.; Calandra, T.; De Backer, D.; Welte, T.; Antonelli, M.

Keywords

  • Anti-Bacterial Agents/*pharmacology/*therapeutic use
  • *Critical Illness
  • Humans
Publication details
DOI: 10.1186/s13054-016-1285-6
Journal: Critical care (London, England)
Pages: 133 
Number: 1
Work Type: Review
Location: BREATH
Disease Area: PALI
Partner / Member: MHH
Access-Number: 27184564
See publication on PubMed

DZL Engagements

chevron-down